Solventum Co. (NYSE:SOLV) Shares Sold by Fjarde AP Fonden Fourth Swedish National Pension Fund

Fjarde AP Fonden Fourth Swedish National Pension Fund cut its position in Solventum Co. (NYSE:SOLV) by 6.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 26,584 shares of the company’s stock after selling 1,800 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Solventum were worth $1,756,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Blue Trust Inc. boosted its stake in shares of Solventum by 2.1% in the fourth quarter. Blue Trust Inc. now owns 7,872 shares of the company’s stock worth $549,000 after buying an additional 161 shares during the last quarter. MML Investors Services LLC boosted its stake in shares of Solventum by 3.2% in the third quarter. MML Investors Services LLC now owns 5,345 shares of the company’s stock worth $373,000 after buying an additional 168 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. boosted its stake in shares of Solventum by 4.2% in the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 4,966 shares of the company’s stock worth $346,000 after buying an additional 200 shares during the last quarter. Savant Capital LLC boosted its stake in shares of Solventum by 6.3% in the fourth quarter. Savant Capital LLC now owns 3,914 shares of the company’s stock worth $259,000 after buying an additional 233 shares during the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd boosted its stake in shares of Solventum by 2.0% in the fourth quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,677 shares of the company’s stock worth $904,000 after buying an additional 264 shares during the last quarter.

Analyst Ratings Changes

A number of analysts have recently commented on SOLV shares. Piper Sandler upped their target price on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research note on Friday, November 8th. Mizuho initiated coverage on Solventum in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 target price on the stock. Bank of America increased their price target on Solventum from $80.00 to $85.00 and gave the stock a “neutral” rating in a research report on Wednesday. Finally, Morgan Stanley increased their price target on Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research report on Monday, November 11th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Solventum presently has a consensus rating of “Hold” and an average price target of $71.86.

Solventum Trading Up 0.3 %

NYSE SOLV opened at $83.83 on Thursday. The stock’s 50 day simple moving average is $71.92 and its 200-day simple moving average is $69.63. Solventum Co. has a 1-year low of $47.16 and a 1-year high of $96.05. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.